➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Johnson and Johnson
McKinsey
Merck
Harvard Business School

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 7,857,737

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,857,737
Title:Oscillating exercise device for shoulder and core strengthening
Abstract: The disclosed device is an oscillating exercise device for strengthening of the muscles comprising the shoulder and the torso. The device is held in the user\'s hand and moved in an oscillating manner to simulate a sports specific movement or for muscle strengthening. The device is composed of a tube with internally threaded ends, detachable, threaded end caps, hinged clamshell handle, weight mass and elastic resistance bands. The end caps house springs that extend into the tube when screwed to the ends of the tube. The weight is of a diameter such that it may travel freely along the inner length of the tube, yet closely matched to the inner diameter of the tube such that significant air compression occurs in front of the moving weight. The generated air compression slows the velocity of the traveling weight and reduces the shock of the weight when it impacts the springs at the tube ends. An attachable handle allow for improved simulation of sports specific throwing motions. The elastic resistance bands attach to the tube by way of the clamping handle unit and provide directional resistance during sports related training exercises.
Inventor(s): Ware; Arthur Nelson (Madison, MS), Parsell; Douglas Eric (Ridgeland, MS)
Assignee:
Application Number:12/590,987
Patent Claims:see list of patent claims

Details for Patent 7,857,737

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
AstraZeneca
Baxter
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.